why choose us

First received: October 20, 2022

Clinical Trial: Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Post COVID-19 Condition

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ampligen® in Patients With Post-COVID Conditions

Brief Summary: The purpose of this study is to assess the efficacy and safety of Ampligen® administered twice weekly by intravenous (IV) infusions in subjects experiencing the Post-COVID Condition of fatigue.

Read more